Chatham Capital Group Inc. lowered its position in shares of Merck & Co., Inc. (NYSE:MRK) by 7.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 43,682 shares of the company’s stock after selling 3,625 shares during the period. Chatham […]
